NPI: 1811926504 · NEPTUNE, NJ 07753 · End-Stage Renal Disease (ESRD) Treatment Clinic/Center · NPI assigned 07/03/2006
Authorized official WINSTEL, JOHN controls 20+ related entities in our dataset. Read more
| Authorized Official | WINSTEL, JOHN (CHIEF ACCOUNTING OFFICER) |
| NPI Enumeration Date | 07/03/2006 |
Other providers sharing the same authorized official: WINSTEL, JOHN
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 7,879 | $1.26M |
| 2019 | 7,852 | $882K |
| 2020 | 8,455 | $513K |
| 2021 | 8,609 | $310K |
| 2022 | 18,777 | $387K |
| 2023 | 7,459 | $181K |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 90999 | Unlisted dialysis procedure, inpatient or outpatient | 22,564 | 1,445 | $2.39M |
| J1270 | Injection, doxercalciferol, 1 mcg | 9,286 | 686 | $457K |
| Q4081 | Injection, epoetin alfa, 100 units (for esrd on dialysis) | 13,039 | 824 | $422K |
| J1756 | Injection, iron sucrose, 1 mg | 3,247 | 694 | $114K |
| A4657 | Syringe, with or without needle, each | 4,396 | 1,170 | $51K |
| 85041 | 953 | 599 | $21K | |
| 85048 | 953 | 599 | $21K | |
| 83970 | 683 | 443 | $18K | |
| 82728 | 382 | 283 | $15K | |
| 83550 | 285 | 228 | $13K | |
| 83540 | 402 | 267 | $13K | |
| 82746 | 12 | 12 | $2K | |
| 82108 | 14 | 14 | $2K | |
| J0887 | Injection, epoetin beta, 1 microgram, (for esrd on dialysis) | 413 | 117 | $84.51 |
| G0499 | Hepatitis b screening in non-pregnant, high risk individual includes hepatitis b surface antigen (hbsag), antibodies to hbsag (anti-hbs) and antibodies to hepatitis b core antigen (anti-hbc), and is followed by a neutralizing confirmatory test, when performed, only for an initially reactive hbsag result | 65 | 24 | $1.71 |
| G0009 | Administration of pneumococcal vaccine | 13 | 12 | $0.00 |
| G0008 | Administration of influenza virus vaccine | 15 | 15 | $0.00 |
| 0002A | 16 | 13 | $0.00 | |
| OP250 | 2,293 | 50 | $0.00 |